MAG200 knee injection for osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This trial tests if a new medication called MAG200, injected into the knee, can reduce pain and improve function in people with moderate to severe knee osteoarthritis. You will receive either the study drug or a placebo (an inactive substance) to compare results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 75 years old.
- You have a body mass index (BMI) between 19 and 35.
- You have been diagnosed with osteoarthritis of the knee and X-rays show moderate changes (Grade 2 or 3).
- You have had knee pain for at least the past week that is moderate to severe when you move.
- You have tried treatments like pain medication, physical therapy, or weight management in the last year.
- Your knee must not have severe deformity (less than 5 degrees of bow-legged or knock-kneed shape).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This Phase 2 study tests whether injected umbilical-cord stem cells can improve safety and reduce symptoms in people with moderate knee osteoarthritis. It focuses on people with significant knee pain who have not gotten enough relief from standard, non-procedure treatments.
This study tests a potential new treatment for knee osteoarthritis using stem cells from umbilical cord tissue. The therapy is injected into the knee to see if it can reduce pain and improve function, and it's being compared to a placebo.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
Hear when a new Knee Osteoarthristis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.